Breast cancer bone metastases secrete various soluble factors4–6, which stimulate osteoclast-mediated bone resorption through the dysregulation of osteoblastic receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG) expression7. Here, TNFRSF11B is linked to breast carcinoma.